33
/fr/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 30, 2025
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Close
Create a timeline
Public timelines
FAQ
About & Feedback
Un accord
Confidentialité
FAQ
Support 24/7
Cabinet
Get premium
Donate
Éditer
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
Share
End dates of pivitol studies
Category:
Autre
mise à jour avec succès:
5 nov. 2018
0
0
384
Auteurs
Created by
letrishka
Attachments
Comments
Payload timeline
By
letrishka
3 sept. 2018
0
0
501
Les événements
Anetumab ravtansine Mesothelioma
Mirvetuximab soravtansine
Polatuzumab vedotin Diffues large B-cell lymphoma
Enfortumab vedotin Urothelial bladder cancer
Trastuzumab duocarmazine HER-2+ve breast cancer
Trastuzumab deruxtecan Breast cancer
Depatuxizumab mafodotin Glioblastoma
Mirvetuximab soravtansine Ovarian cancer (PROC)
Sacituzumab govitecan Triple negative breast cancer (TBNC)
Rova-T (TRINITY) Small cell lung cancer
About & Feedback
Un accord
Confidentialité
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments